JP2013501940A - 被分析物メータのためのグラフィカルインタフェース - Google Patents
被分析物メータのためのグラフィカルインタフェース Download PDFInfo
- Publication number
- JP2013501940A JP2013501940A JP2012524840A JP2012524840A JP2013501940A JP 2013501940 A JP2013501940 A JP 2013501940A JP 2012524840 A JP2012524840 A JP 2012524840A JP 2012524840 A JP2012524840 A JP 2012524840A JP 2013501940 A JP2013501940 A JP 2013501940A
- Authority
- JP
- Japan
- Prior art keywords
- meter
- processing unit
- test sensor
- test
- user interface
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 21
- 238000012545 processing Methods 0.000 claims abstract description 88
- 238000012360 testing method Methods 0.000 claims abstract description 74
- 238000000034 method Methods 0.000 claims abstract description 36
- 238000005259 measurement Methods 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 238000010998 test method Methods 0.000 claims description 10
- 238000004891 communication Methods 0.000 claims description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 9
- 230000002159 abnormal effect Effects 0.000 abstract description 6
- 230000000007 visual effect Effects 0.000 abstract description 3
- 239000012530 fluid Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 238000007689 inspection Methods 0.000 description 10
- 238000009413 insulation Methods 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 238000013523 data management Methods 0.000 description 3
- 238000000840 electrochemical analysis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 206010014357 Electric shock Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009529 body temperature measurement Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23311309P | 2009-08-11 | 2009-08-11 | |
| US61/233,113 | 2009-08-11 | ||
| PCT/US2010/045175 WO2011019820A2 (en) | 2009-08-11 | 2010-08-11 | Graphical interface for analyte meter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013501940A true JP2013501940A (ja) | 2013-01-17 |
| JP2013501940A5 JP2013501940A5 (enExample) | 2013-09-19 |
Family
ID=43086837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012524840A Pending JP2013501940A (ja) | 2009-08-11 | 2010-08-11 | 被分析物メータのためのグラフィカルインタフェース |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20120142084A1 (enExample) |
| EP (2) | EP3352108B1 (enExample) |
| JP (1) | JP2013501940A (enExample) |
| ES (1) | ES2903107T3 (enExample) |
| WO (1) | WO2011019820A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015105713A1 (en) * | 2014-01-10 | 2015-07-16 | Bayer Healthcare Llc | Methods and apparatus for representing blood glucose variation graphically |
| US9689753B2 (en) * | 2014-05-22 | 2017-06-27 | Roche Diabetes Care, Inc. | Handheld analyte meter with recharging control for improved analyte testing |
| US10436773B2 (en) | 2016-01-18 | 2019-10-08 | Jana Care, Inc. | Mobile device based multi-analyte testing analyzer for use in medical diagnostic monitoring and screening |
| US11536732B2 (en) | 2020-03-13 | 2022-12-27 | Jana Care, Inc. | Devices, systems, and methods for measuring biomarkers in biological fluids |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030050537A1 (en) * | 2000-06-22 | 2003-03-13 | Guidance Interactive Technolgies | Interactive reward devices and methods |
| JP2003302406A (ja) * | 2002-04-05 | 2003-10-24 | Sony Corp | 自己血糖測定システムおよび自己血糖測定ユニット |
| JP2005525161A (ja) * | 2002-05-14 | 2005-08-25 | ヘルスピア カンパニー，リミテッド | 血糖測定装置及びデータアップロード方法 |
| WO2007118046A2 (en) * | 2006-04-03 | 2007-10-18 | Home Diagnostics, Inc. | Diagnostic meter |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1457913B1 (en) * | 1998-07-31 | 2008-12-17 | Abbott Laboratories | Method of managing data for a plurality of analyte test instruments |
| EP1397068A2 (en) * | 2001-04-02 | 2004-03-17 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
| US9529762B2 (en) * | 2003-06-30 | 2016-12-27 | Becton, Dickinson And Company | Self powered serial-to-serial or USB-to-serial cable with loopback and isolation |
-
2010
- 2010-08-11 WO PCT/US2010/045175 patent/WO2011019820A2/en not_active Ceased
- 2010-08-11 EP EP18154034.5A patent/EP3352108B1/en active Active
- 2010-08-11 EP EP10752465.4A patent/EP2465063B1/en active Active
- 2010-08-11 ES ES18154034T patent/ES2903107T3/es active Active
- 2010-08-11 JP JP2012524840A patent/JP2013501940A/ja active Pending
- 2010-08-11 US US13/389,778 patent/US20120142084A1/en not_active Abandoned
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030050537A1 (en) * | 2000-06-22 | 2003-03-13 | Guidance Interactive Technolgies | Interactive reward devices and methods |
| JP2003302406A (ja) * | 2002-04-05 | 2003-10-24 | Sony Corp | 自己血糖測定システムおよび自己血糖測定ユニット |
| JP2005525161A (ja) * | 2002-05-14 | 2005-08-25 | ヘルスピア カンパニー，リミテッド | 血糖測定装置及びデータアップロード方法 |
| WO2007118046A2 (en) * | 2006-04-03 | 2007-10-18 | Home Diagnostics, Inc. | Diagnostic meter |
| JP2009532706A (ja) * | 2006-04-03 | 2009-09-10 | ホーム ダイアグナスティックス，インコーポレーテッド | 診断測定器 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011019820A2 (en) | 2011-02-17 |
| EP2465063A2 (en) | 2012-06-20 |
| US20120142084A1 (en) | 2012-06-07 |
| WO2011019820A4 (en) | 2011-07-28 |
| EP3352108B1 (en) | 2021-10-06 |
| EP3352108A1 (en) | 2018-07-25 |
| WO2011019820A3 (en) | 2011-05-05 |
| ES2903107T3 (es) | 2022-03-31 |
| EP2465063B1 (en) | 2018-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104203097B (zh) | 医疗监测中的电池状态检测和存储方法以及系统 | |
| JP5329562B2 (ja) | 試験システム | |
| US20170156642A1 (en) | Information Processing Apparatus and User Terminal | |
| TWI629478B (zh) | 分析儀、數位電路及操作分析儀之方法 | |
| US20140118104A1 (en) | Low Energy Communication of Medical Monitoring Information | |
| US20140318987A1 (en) | Analyte meter test strip detection | |
| JP2013501940A (ja) | 被分析物メータのためのグラフィカルインタフェース | |
| AU2019201087A1 (en) | Orientation independent meter | |
| CN102046804A (zh) | 测试装置的用户界面 | |
| CN110291398A (zh) | 信息提供方法、信息处理系统、信息终端及信息处理方法 | |
| JP2013076598A (ja) | 医療機器、エラー情報処理システム及びエラー情報処理プログラム | |
| WO2014178085A2 (en) | A system integrated with communicating device for medical analysis of biological matter | |
| List et al. | Performance evaluation and labeling comprehension of a new blood glucose monitoring system with integrated information management | |
| HK1152079A (en) | User interface for testing device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130726 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130726 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131119 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131120 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140206 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140214 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140603 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20150305 |